The award was due to be presented at the association's annual shindig in March, which was cancelled due to the coronavirus pandemic.
VMA Awards chair, Claire Edmunds, said: “This years’ winners will still get their moment of glory on stage next March at the rescheduled event. We can also announce that the event is likely to include some additional categories to recognise campaigns and initiatives undertaken during the COVID-19 pandemic.”
Carlos Michelsen, managing director of award sponsor, CM Research, added: "Thanks to the continued success of Cytopoint, Zoetis achieved highly commended status. But it was Elanco that came in as award winners, with their novel veterinary pharmaceutical product Galliprant taking the crown. Congratulations to Elanco!"
Rebecca Bryant, Elanco’s marketing manager for Pet Health Therapeutics (pictured right), said “Elanco is delighted to be recognised by the veterinary community with this prestigious award for Galliprant. The UK team is proud to be part of the launch of this innovative, first-in-class product which has already enriched the lives of thousands of pet owners and their dogs living with osteoarthritis. It’s fantastic to hear from vets that managing OA with Galliprant has already made a positive impact on their practices.”
Zoetis product manager, Allison Henry said: “We are very proud to come such close second in this award category as it is a true testament to the lasting innovation Cytopoint has brought to our industry, customers and pets. At Zoetis, we always strive to develop innovative new medicines for the veterinary industry and we are thrilled to see how Cytopoint has done just that.”
The information has been made available amid concerns from behaviourists and animal welfare organisations that there may be a rise in behavioural issues as lifestyle restrictions are lifted.
The Q&A explains what some of the behavioural concerns are and how they can be prevented and managed. Topics include separation-related issues, animals becoming anxious as the world around them becomes busier and noisier, and puppies lacking appropriate skills when greeting animals (including dogs and people) from other households.
The Q&A can be downloaded here.
Dr Hannah Donovan, vet, clinical animal behaviourist and Social Media Officer at the BVBA said: “We hope that this information will help vets to support their clients and their pets when faced with potential challenges as we transition out of lockdown.”
Professor Ian Ramsey, President of the BSAVA added: “This guidance has been developed in collaboration with the BVBA with the intention of supporting vets in practice in an ever-changing environment. It sits alongside other practical BSAVA resources vets can share with pet owners, such as Vaccination Guidance and Neutering Guidance, and follows the BSAVA’s core ethos – ‘By the profession for the profession.”
The BSAVA has also created a collection of resources for veterinary professionals relating to the prevention, management and treatment of behavioural issues in cats of dogs, which is freely available in the BSAVA Library until the end of July.
The collection includes chapters from the BSAVA Manual of Canine and Feline Behavioural Medicine; for those wishing to buy the full manual, there is a £10 discount on both the print and online editions throughout July (using code BEHAV10 on checkout).
Further information for vets can be found in the BSAVA’s COVID-19 resources here.
The survey was held in mid-June and gathered 196 responses from UK practices. That compared with the 532 responses to the initial survey conducted early in April and 251 responses to the second survey conducted at the start of May.
One of the main findings was a marked increase in the number of practices running a near-normal caseload, from 3% in May to 32% in June. Practice turnover data similarly reflected a shift back towards normality, with 46% now reporting a reduction of less than 25%, compared with 19% last month.
Other findings included:
Lizzie Lockett, RCVS CEO, said: "This latest survey has demonstrated a continuation of the previous survey’s positive trends including an increase in practice turnover with more practices approaching a ‘near normal caseload’ and with a reduction in the number of practices impacted by staff self-isolating or with confirmed cases of Covid-19.
“In this survey we also asked about what difficulties practices may be experiencing with EMS placements for vet students and VN training placements as a result of Covid-19, and this will help us to understand how we can better support students and practices in these areas.
“We will continue to monitor the situation via these regular surveys, with the next one planned for later this summer. I would urge as many practices as possible to continue to complete them, so that we can build up a stronger evidence-base on how veterinary businesses have been affected and how they are recovering.
"This information is not only vital for our own policy decisions but also allows us to present a stronger case to the Government and other public bodies where we wish to influence the decisions they make that will impact the veterinary professions and businesses.”
The survey results can be read in full at www.rcvs.org.uk/coronavirus-resources.
The Stablelab hand-held reader detects and quantifies the biomarker Serum Amyloid A (SAA), an acute phase protein produced by the liver that increases rapidly and dramatically in response to inflammation.
Zoetis says that by measuring SAA, vets can assess the severity of an infection more quickly, often before clinical symptoms start, and are able to monitor the horse’s response over the course of treatment.1
Zoetis vet Wendy Talbot said: “Zoetis is committed to providing vets and horse owners with the most effective health products to better predict, prevent, detect and treat equine disease.
“The Stablelab test kit enables convenient, off-site testing for quick and accurate detection of a reliable indicator of infection in horses.
“Point-of-care testing is one of the fastest-growing areas of diagnostics and this test is rapidly becoming a standard of care in equine practice. SAA testing will help vets to quickly determine an appropriate course of intervention, positively impacting case outcomes.”
For more information, visit: www.stablelab.com. To place an order, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 (option 3).
Reference
Mr Wood pleaded guilty to three charges of making indecent images of children at Portsmouth Magistrate’s Court in December 2017. Following his conviction, Mr Wood was given a community sentence, fined and made subject to a sexual harm prevention order for five years.
Mr Wood’s application for restoration was based on the argument that he was professionally competent to be restored to the Register, that he had strong mitigation for his original conviction (for which he had demonstrated remorse), that he had a low chance of reoffending, had engaged proactively with the Probation Service and rehabilitative courses, and that had completed his community service.
In considering Mr Wood’s application, the Disciplinary Committee took into account a number of factors including Mr Wood’s acceptance of the Committee’s original findings, the seriousness of the original findings, protection of the public, the future welfare of animals in his care should he be restored, the length of time off the Register, his conduct since removal from the Register, efforts by Mr Wood to keep up-to-date with his continuing professional development (CPD), the impact of removal from the Register on Mr Wood and public support for his restoration.
However, on balance, the Committee decided that Mr Wood was not currently fit to be restored to the Register.
Ian Arundale, chairing the Committee and speaking on its behalf, said: "In essence, the Committee decided that the facts of the charge justifying removal from the Register and the underlying criminal behaviour were too serious for Mr Wood to be restored at this time. It concluded that because Mr Wood continued to be subject to a sexual harm prevention order, notification requirements for sexual offenders and because he remained on the Barring List by the Disclosure and Barring service until January 2023, he was not fit to be restored to the Register at this time.
"The Committee accepted that Mr Wood had made significant efforts to rehabilitate himself but it was not persuaded that he was fit to be restored to the Register because ancillary orders relating to the underlying criminal offences remained in force. The Committee noted that at the time those orders were made Mr Wood was described as having an addiction and although the Committee accepted that there was a low risk of future reoffending, it decided that because the orders were still in place for public protection reasons, Mr Wood was not fit to be restored to the Register."
The full report of Mr Wood’s restoration hearing can be found at www.rcvs.org.uk/disciplinary
Backed by RJD Partners, the directors bought the company back from Benchmark Plc for a reported £12.75M after it decided to divest itself of all non-aquaculture-related assets.
Improve says that under its new leadership, it plans to expand its e-learning portfolio significantly, harnessing technologies like video teaching and virtual/augmented reality to offer a richer learning experience.
The company will continue to offer attended modular training options as well as small group practical teaching sessions at its wet labs in Swindon and Sheffield. It says these events will complement its online programmes and will provide stand-alone training for vets wishing to learn new surgical and diagnostic skills.
In collaboration with its assessment partner, the International School of Veterinary Postgraduate Studies (ISVPS), Improve will be developing new distance-learning programmes, together with exams that can be taken remotely.
Improve also plans further geographical expansion, including running programmes in languages including French, Spanish, German and Chinese.
Dr Heber Alves (pictured right) is Improve’s new CEO. He is supported by a management team that includes Improve founder Dr David Babington, Business Development Director and Mr John Douglass, UK Managing Director.
Heber said: “Improve is fully owned by a team of experienced veterinary and business professionals with a unique understanding of the profession’s training needs at a global level. Even better, we are backed by a private equity partner with a strong track record in professional education and a commitment to supporting our growth, both organically and through acquisition.
“We start this new chapter in a world changed irrevocably by COVID-19. It is a world in which veterinary professionals are demanding more flexible ways of learning and showing a hunger to achieve additional qualifications. With this in mind, we will be working to offer a combination of high quality practical, remote and blended learning that will make the achievement of a postgraduate qualification a realistic ambition for every vet."
Floxabactin is indicated for use in dogs with lower UTIs including those associated with prostatitis, upper urinary tract infections caused by Escherichia coli or Proteus mirabilis in dogs, and superficial and deep pyoderma. For cats, the 15 mg dose can be used with upper respiratory tract infections.
Floxabactin is presented in blister packs: 15mg for cats and dogs, plus 50mg and 150mg for dogs.
Dechra Brand Manager Carol Morgan said: “Floxabactin has been developed with the responsible administration of antibiotics in mind. We would always promote only using antimicrobials when an infection has been documented and based on the results of culture and sensitivity testing, and or cytology testing, if applicable.
"Other treatment options should also be considered before the systemic use of antibiotics such as topical treatment for superficial pyoderma."
For more information, visit: https://www.dechra.co.uk/new-from-dechra
The re-categorisation means veterinary practices can sell the topical parasiticides to ‘walk-in clients’ without the need of a prescription.
Andrew Fullerton, veterinary surgeon and product manager at Ceva Animal Health, said: “The new NFA-VPS category for Vectra 3D spot-on solution for dogs and Vectra Felis 423mg/42.3mg spot-on solution for cats provides veterinary practices with greater flexibility to sell easy-to-use, fast and effective parasite prevention and treatment without a prescription."
For more information, contact your Ceva Animal Health account manager or email cevauk@ceva.com.
In an internal study, Royal Canin found that Pill Assist Cat achieved over 91% pill acceptance.
Pill Assist Cat is enriched with vitamins and prebiotics to support a cat’s recovery, and each treat contains only three calories.
Elisabete Capitao, Royal Canin Veterinary Marketing Manager said: "We know that getting cats to take pills can be quite a challenge even for the most experienced pet owners! A quarter of owners leave the veterinary clinic with oral medication for their cat, but 40% find giving pills to their cat complicated. Pill Assist Cat makes giving cats medication easy and takes the stress out of pill time."
Royal Canin says Pill Assist Cat is suitable for most types of medication, from worming tablets to medication for an illness.
The company says the acquisition is a natural fit for its behavioural range and will bolster its Adaptil portfolio with a wider variety of anxiety solutions for dogs.
Abbie King, senior behaviour product manager at Ceva Animal Health, said: “We have always been fans of the ThunderShirt range and we are therefore delighted with the acquisition, which will further strengthen our extensive portfolio of behavioural products that work in synergy with one another to provide pet owners with comprehensive anxiety solutions.”
For more information, visit: www.thundershirt.com
The new devices are an evolution of the original v-gel device launched in 2012, which is widely used in veterinary anaesthesia and resuscitation.
Dr Muhammed Nasir, inventor of v-gel and President of Docsinnovent, said: "Our original product has proven to be extremely popular globally because it makes airway management easier; quicker; more comfortable for patients; and most importantly, safer for patients and staff.
"However, since launch our R&D team have been hard at work to make the devices even better. They are now slimmed down so that there is more room in the mouth for dentistry; they seal even better; and they are single-use, improving standards of hygiene"
Chris Geddes MRCVS, Docsinnovent’s Marketing Manager, added: "Our newly-launched website www.docsinnovent.com includes plentiful information on the new products including two hour-long CPD webinars from Dr Ivan Crotaz detailing how the new devices can be utilised for optimal airway management in anaesthetised patients.”
Information on where to buy the new products can be found at www.docsinnovent.com/distributors
The university says it has implemented a range of health and safety measures to meet Government guidelines and allow for the controlled return of 150 first-year undergraduate students to its Sutton Bonington campus.
Since the latest cohort joined the university at the height of the UK lockdown, the school has delivered a programme of technology-assisted Fresher’s Week and teaching activities.
However, the return of the April cohort will enable face-to-face teaching that cannot be delivered remotely, specifically essential animal handling and health and safety skills required before students can embark on the work experience element of their course.
The practical sessions will form part of a blended approach to learning, with other lectures and tutorial support continuing to be delivered remotely to reduce the number of students in teaching buildings at any one time.
Dean of the School of Veterinary Medicine and Science Professor Gary England said: “We have missed being on campus with our students tremendously during the coronavirus lockdown and we are excited to be welcoming this cohort to Sutton Bonington in July.
“The health and safety of our students and staff has remained our top priority and has been at the heart of our planning process. Colleagues from across the university have been working intensively on the intricate detail required to ensure that adequate social distancing and hygiene measures are in place to allow this first step in a return to campus.”
Among the measures which have been introduced are:
The university says the return of its vet school cohort and the re-starting of face-to face-education at University of Nottingham Ningbo China at the end of April, where 5,000 students are now back on campus, will form the blueprint for the return of the majority of students to its UK campuses when the new academic term begins on 21 September.
Running from 14th-23rd July, the interactive webinars will be delivered in 5 half-day sessions, led by UK pet food consultants, scientists, and vets.
The course includes:
Sarah Hormozi, PFMA Head of Science & Education, said: "With some of the most credible industry experts as our speakers, this is a rare opportunity for pet professionals across the UK and EU to improve and refresh their knowledge of animal nutrition, pet food legislation, marketing regulations and manufacturing methods, from the comfort of their own home or office!”
For the full programme, list of speakers, registration details and prices, visit www.pfma.org.uk/pfma-training-webinar-series.
Everyone who takes part in the survey, which is also open to nurses, practice support staff and veterinary students, will be entered into a free prize draw for the chance to win a 1 of 3 Amazon gift vouchers (up to the value of £200).
Lizzie Erian-Round, Head Veterinary Healthcare Advisor at Pegasus (pictured right) said: "With lockdown measures easing, it is a good time to take a deeper dive into what the future looks like. And importantly, how veterinary professionals feel about it. No one has a crystal ball but those on the veterinary frontline are already getting a sense of what could lie ahead. And we believe it’s important they get to share their view of what good support and communications look like.
Our last wave of research indicated that COVID-19 could be a major catalyst for future digital innovation and have lasting consequences for the way we practice. With that in mind we’ve focussed our new survey to be more forward facing."
Pegasus's last survey found that 84% of veterinary professionals thought that the coronavirus pandemic would change the way veterinary practices operate in the future. 78% thought more owners will buy their medicines online. 71% worried about their exposure to coronavirus at their work place and 68% worried about the impact of the pandemic on their mental wellbeing.
The survey closes at 9am GMT Tuesday 30th June The results will help animal health companies better understand how to best support and communicate with the veterinary profession beyond the pandemic.
To take part in the survey, visit: https://www.surveymonkey.co.uk/r/DRWSNWT
For a copy of the results, which will be available in July, email: animal@thisispegasus.co.uk.
The traditional approach is to use anatomical knowledge to inject pain relief in the area of the nerves to be blocked.
Liz is leading a move away from this approach to a more precise method which uses ultrasound guidance to visualise the nerves, allowing the local anaesthetic to be placed directly around the nerve itself.
For some nerve blocks, it is possible to block just the sensory branches of nerves, which means pets can walk better immediately after surgery while not feeling any pain.
Liz, a past president of the Association of Veterinary Anaesthetists, said: “Local analgesia is now at the forefront of our post-operative care and reliably improves the quality of a pet’s recovery and reduces the need for opioid pain relief, which can cause side effects.
“We’re using the latest techniques to deliver the nerve-blocking anaesthetics to exactly where they’re needed.
“For many of the nerve blocks, the use of ultrasound guidance allows more precise delivery and a complete blockade of the sensory nerves, which is why, here at Paragon, we’ve invested in state-of-the art ultrasound machine designed specifically for superficial and deep nerve blocks.
“This means we can provide more effective immediate post-operative analgesia for our patients and minimise the need for further pain killers.
“The nerves can be directly visualised and local anaesthetic directly placed around the nerve bundles.”
Liz is keen to highlight the advantages of the increased use of local anaesthesia in the treatment of animals. She added: “We’re hoping we’ll soon be able to publish some clinical research on the use of some of the blocking techniques used to demonstrate our clinical impression of their effectiveness in patient management.”
Speakers at the free event will include feline expert Dr Andy Sparkes, BVetMed, PhD, DipECVIM, MANZCVS, MRCVS and the immunologist who led the Purina research behind Liveclear, Dr Ebenezer Satyaraj, PhD.
Andy will address the consequences of feline allergy. He says that in majority of cases, cat-allergic owners will choose to tolerate ongoing symptoms of allergy, rather than relinquish their cats, even when they have severe symptoms.
Ebenezer will talk about the research behind Pro Plan Liveclear and how it will allow veterinary surgeons and nurses to help support these clients.
Libby Sheridan, MVB MRCVS, Purina Veterinary Technical Affairs Manager, UK & Ireland said: "This innovation is safe for cats who continue to produce the major cat allergen, Fel d 1, which is found mainly in the cat's saliva and sebaceous glands.
"Our researchers found that the Fel d 1 protein could be neutralised through feeding a nutritious cat food coated with an innovative egg product ingredient containing anti-Fel d 1 antibodies1 which helps reduce the active allergen transferred to hair and dander during grooming, and ultimately helps reduce active Fel d 1 in the environment.2
"Now the science has resulted in a commercially available product that could have a big impact on the quality of life of the cat and their owner. We'll be sharing the research behind this at the symposium so that clinicians can evaluate the potential benefits."
Any member of the practice team can register for the event at www.veterinarywebinars.com/purina, and will be entered into a prize draw to win an iPad. There will also be a number of goody bags available as additional prizes.
More information about the science is available at www.purinainstitute.com.
References
The authors say that an association between acute kidney injury and general anaesthesia is well-defined in human medicine, but there is little information in the veterinary literature.
In their new study, called “Twelve previously healthy non-geriatric dogs present for acute kidney injury after general anaesthesia for non-emergency surgical procedures in the UK1”, Emma Rogers-Smith and her co-authors retrospectively analysed the medical records of 12 dogs that presented for acute kidney injury following general anaesthesia across three multidisciplinary referral centres and one primary care practice in the UK. Information obtained included signalment, general anaesthesia, surgical procedure and peri-surgical management.
The aim was to characterise common factors after a suspected increase in incidence of post-procedure acute kidney injury in animals without identifiable risk factors.
Emma Rogers-Smith, a resident in internal medicine at Davies Veterinary Specialists and corresponding author for the paper, said: “A suspicion that there was an increase in non-geriatric dogs suffering acute kidney injury (AKI) shortly after elective procedures led to this study.
"Whilst our data supported this suspicion, there was an increase in incidence, the change itself is not statistically significant and so we are unable to be conclusive.
"This study is limited by small sample size and retrospective nature of the data. At this time no definitive causal link between these cases has been found.
"As such, we are urging clinicians with similar experiences in the last 24 months to get in touch. We hope to ascertain if there is any commonality between these cases and, if possible, better define the incidence of AKI in non-geriatric animals following elective procedures.”
Nick Jeffery, editor of JSAP said: “Nowadays, most veterinarians consider general anaesthesia safe in dogs and routinely allay pet-owner concerns. Whilst AKI following general anaesthesia seems to be rare, it is worrying that a specific risk factor was not identified in any dog, despite a wealth of available clinical data. I would urge any veterinarians that have similar cases to contact the authors.”
Any clinicians with similar experiences during the last 24 months should contact Emma Rogers-Smith on emma.rogers-smith@vetspecialists.co.uk.
The full article can be found in the June issue of the Journal of Small Animal Practice, and here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13134
As the company points out, there is a lot of catching up to do as practices return to the new normal, plus a cohort of pet owners who remain at risk or reluctant to visit their vets. Online consultations, phone consultations and home delivery services such as VetPost can help to get the revenue back in to the practice.
Mark Johnston from Video With My Vet said: "Video With My Vet was designed and developed to enable the client to have consultations with their own practice because the client/patient relationship will already be in place, meaning the clinicians at the practice will have the context of the previous consultations and clinical procedures with the practice to refer to."
Vet-AI/Joii co-founder Robert Dawson, said: “Here at Joii we are looking to develop long-term, mutually beneficial relationships with forward-thinking practices, focused on providing fantastic customer care. As a practice owner for 25 years I am very aware of the stresses and strains of normal vet practice life and once lock down is lifted it may not be practicable for most practices to provide dedicated remote care for their patients and clients. We want to integrate with physical veterinary practices to work together to provide the best possible customer journey, where clients can access telemedicine instantly and where any cases needing face to face care can be triaged seamlessly into practice.”
Essentially, the difference between the two propositions is that 'Video With My Vet" is a platform for practices to provide their own telemedicine service for their clients, whereas Vet-AI/Joii provides clients with advice from its own vets, referring them back to their practice as needed.
For further information, contact your Zoetis Account Manager or Customer Services 0845 300 8034.
The company makes personalised, calorie-controlled fresh meals for dogs; 20 million of them since it launched in 2016.
Each recipe is made of human-grade ingredients and contains 60% single-source protein and 40% vegetables and lentils, with added minerals. There are no preservatives, derivatives or byproducts. Recipes such as "Chow Down Chicken," "Gobble Gobble Turkey," and "Swish Fish Dish" contain less than 5% fat content.
The meals are portioned specifically to each dog according to their calorific need. They are then delivered directly to the customer's door (free-of-charge) via a subscription model.
The model has proven so successful that Butternut Box has recently secured £20m in venture capital to grow the business.
The company launched a referral programme in early May, in which over 50 veterinary surgeons and nurses have signed up to become Butternut Box 'ambassadors'.
Each ambassador is give a unique discount web address which they can give to any client that would benefit from a freshly cooked, calorie-controlled diet for their dog.
If the client redeems the code, a one-time referral fee is credited to the ambassador's account, which can be transferred to a personal account, donated to charity or spent on Butternut Box food for their own use.
Kyle Kennedy from Butternut Box said: "We take great pride in the quality of our food. We think dogs deserve better, and we want to give pet professionals a food they can be proud to recommend."
For more information about being a Butternut Box ambassador, email: kyle@butternutbox.com.
The company says the new product has been 10 years in development and uses 'Soft Mist' technology - developed originally for human use by its pharma business - to deliver medication deep into the horse's lungs.
The active ingredient in the Aservo EquiHaler is ciclesonide, a corticosteroid that is activated directly in the lung, reducing the lower airway inflammation associated with severe equine asthma and reducing the risks commonly associated with systemic corticosteroids.
The Aservo EquiHaler does not use a propellant, so it does not contribute to greenhouse gas emissions. Boehringer also highlights that it is made from up to 50% recycled materials. In April, the product was awarded a Red Dot Design Award.
Dr Marc Laemmer, Head of Equine in UK & Ireland said: "It's another industry first and is a strong indicator of the commitment that Boehringer Ingelheim has to the health and welfare of horses, and to the investment that we make into continuing to advance therapies through collaboration and innovation.
"We understand that a product launch in this challenging time for the veterinary profession may seem surprising, but we have had such strong demand from equine vets for the product that we have committed to making Aservo EquiHaler available. Out team of territory managers and vet advisers will conduct remote meetings with customers to make sure that they have the information and support they require."
The company says Dormazolam works in synergy with other induction agents to provide an extended duration of anaesthesia without adversely affecting the quality of recovery 2,3,5.
Benzodiazepines are commonly incorporated into anaesthetic regimens to alleviate issues seen with the administration to ketamine alone2,3,4, including inadequate muscle relaxation2,3,4, anaesthesia not lasting long enough2 and induction failure2.
Despite the issues caused by the sole use of ketamine, it remains the primary anaesthetic induction agent of choice for more than 90% of equine vets2.
Dechra Brand Manager Emma Jennings said: “Using Dormazolam as part of an equine anaesthesia protocol will give optimal general anaesthetic conditions every time, including a rapid onset of action1.
"Anaesthetic co-induction with ketamine and midazolam has been shown to provide a superior quality of anaesthesia compared to ketamine alone3 and midazolam is equally as effective as diazepam when used as a co-induction agent alongside ketamine4. It also cuts down on the number of ketamine ‘top-up’ doses required compared to using ketamine3 alone.
"Additional benefits include no clinically significant differences in cardiopulmonary function1 or recovery times1 between midazolam and diazepam and it can be mixed in the same syringe as ketamine for ease of use4.”
Emma added: “The introduction of Dormazolam provides an exciting new option for equine vets. It delivers enhanced anaesthetic and surgical conditions by improving anaesthetic induction quality2,3,4 and giving better surgical relaxation scores2,3,4. It also reduces involuntary movements because, as a co-induction agent, midazolam only causes minimal cardiovascular and pulmonary depression2,4.”
Dormazolam is available in a 20 ml vial. It has a shelf life of four years and a broached shelf life of 28 days.
For more information, visit: www.dechra.co.uk/therapy-areas/equine/anaesthesia/analgesia.
References:
Alan, who is MD of the veterinary business consultancy, Vet Dynamics, will be looking at finances, the team, and scoping out a future strategy. The session will provide practical planning tools, strategic advice, and the opportunity to ask questions.
Bayer points to a number of trends which have emerged during lockdown which it says practices must respond to quickly in the post-lockdown recovery.
The company says retailers have reported that internet traffic increased threefold at the start of lockdown and it remains at double the pre-lockdown levels. Direct retail sales of flea and tick products have also increased.
This suggests that owners are becoming more comfortable with buying preventative healthcare products online.
Bayer says there is a business opportunity here for practices. The subscription box market is expected to hit £1 billion by 20222, and one way practices can capitalise on this trend is by offering home-delivered flea, wormer and tick treatments.
Another business opportunity could lie in research by Banfield Pet Hospital among 1,000 US pet owners in which 20% vowed to take their pets ‘more often’ to the vet post-lockdown for preventative care checkups3.
Caroline Braidwood, Regional Business Manager of Bayer Animal Health said: "We know that many veterinary customers have potentially gone elsewhere during the pandemic and vets will need to work hard to win them back. Our webinar will provide tangible insights to ensure that practices can flourish. Whether you’ve worked with Bayer or not, our team of Veterinary Business Managers are here to help. We’re all in this together, and with some planning, we can ensure the veterinary industry continues to grow.”
To book your webinar place, visit: https://event.webinarjam.com/register/46/rk71qav5
Owners are being asked to provide a photo or video and a brief description that capture what it is like to live with and care for an older dog.
Dr Carri Westgarth, a senior lecturer in human-animal interaction at the University of Liverpool, has been awarded a citizen science grant from PetSavers to run the project. She plans to use the information gathered to help develop a ‘Canine Ageing and Wellbeing’ tool for use in veterinary practice.
Carri said: “Dogs are living up to twice as long as they did 40 years ago and there are implications for senior dogs’ healthcare and wellbeing.
"As life expectancy increases, so does the amount of time the dog may spend in poor health. It may be difficult for us to distinguish between the signs of serious age-related diseases and normal age-related changes in our dogs."
PetSavers says the data will contribute to our investigations of owner expectations, experiences and attitudes to ageing in dogs, including preventative care and general understanding of normal and abnormal changes during ageing.
Carri added: "Improving discussions between owners and veterinary professionals about senior dog care will help to increase owner understanding and involvement in care decisions for their pet. The resulting early detection of health problems should bring significant improvement to the quality of life of senior pets and the dog-owner relationship.
"Any adult UK residents who (currently or recently) live with an aged dog/s of any breed/s or health status are encouraged to participate by choosing an image or short video and telling us about it."
The research team will then analyse the submitted text and media for common themes. They may also use anonymised selected quotes to illustrate important findings in research publications such as scientific papers or conference presentations.
If you know any owners who might like to participate, do share this link with them: https://bit.ly/PetSaversOAPsPhoto
For more information, visit: https://www.petsavers.org.uk/our-research/oldagepets
Data collection will close on Friday 10th July 2020.
Purina carried out a survey earlier this year which revealed the different ways British cat owners manage sensitivity to cat allergens2. They included removing the cat when sensitivities to allergens act up (76%), restricting the cat to specific places in the home (75%), using special cat products on the cat such as dander removers or allergen sprays (64%), bathing the cat (56%) and taking the cat to a groomer (52%).
92% also use a high-quality vacuum cleaner, 66% put covers on their furniture and 26% clean their home and furniture daily to remove traces of cat hair.
Dr Ebenezer Satyaraj, PhD, immunologist for Nestlé Purina Research and lead investigator on the research that led to the development of Pro Plan LiveClear, said: “Many people think that cat hair or dander is the allergen, but it’s actually what’s on it – the major cat allergen called Fel d 1, a protein that cats produce naturally in their saliva.” 3,4
All cats produce Fel d 1, regardless of breed, age, hair length, sex or body weight, but at differing levels.4-6 When cats groom themselves, Fel d 1 gets on the hair and skin through the saliva and with shedding, it eventually gets into the home environment. Feld d 1 attaches itself to any surface it comes into contact with and remains in houses for over a year or more.
Purina says Pro Plan LiveClear contains a specific protein, sourced from eggs, which binds itself to the Fel d 1 and safely neutralises it in the cat’s mouth, thereby reducing the amount of active allergen shed in the environment 7,8.
In a study, feeding Pro Plan LiveClear was shown to reduce the allergens on cat hair and dander by an average of 47%, starting in the third week of daily feeding7.
There have been no studies as yet which have tested the effect of this allergen reduction on human symptoms, but Purina says anecdotal evidence from consumers who have tried the product has been positive thus far.
Amena Warner, Head of Clinical Services at Allergy UK said: "Amena Warner, Head of Clinical Services at Allergy UK said: "There are a number of ways in which cat owners try to manage their exposure to cat allergens and keep their symptoms at bay, including taking antihistamines, using inhalers for quick symptoms relief as sensitivity to cat allergens is often linked to allergy-related asthmas, regularly cleaning and hoovering, bathing and grooming the cat by non-allergic family members. And if these measures do not work, current medical advice is often to relinquish the pet to limit exposure to the allergens.
"Every cat is unique though, and so the level of Fel d 1 they produce varies, just as every person's sensitivity level to these allergens is different. That is why there is no ‘one size fits all’ way to manage exposure to cat allergens. Every little bit helps so a combination of management tools often works best to help reduce cat allergens in your home - the combination is unique to your lifestyle. We welcome the development of Pro Plan LiveClear, which when used as part of a cat allergen management regime, could be a meaningful extra tool for affected households.”
Purina says Pro Plan LiveClear is not intended to replace other cat allergen-reduction strategies but to add another measure that can help reduce the cat allergen burden in cat households.
Pro Plan LiveClear is available at Pets at Home retail stores and from the Purina online shop as a complete life-stage range with six products tailored for Kitten, Adult and Adult 7+.
The data shows a stable population of 12m pets, as follows:
There were also:
The survey also provides an interesting point at which to note some historical trends. Whilst cats and dogs have always been the most popular pets, 50 years ago it was budgerigars that held third place. Since then, the dog population has grown 76% and the cat population has grown 63%, whilst rabbits have moved into third place.
Nicole Paley, PFMA Deputy Chief Executive, said: "Almost half of UK households are benefitting from pet ownership and whilst cats and dogs continue to be the most popular pets, rabbits came in at third place followed by indoor birds, guinea pigs and domestic fowl.
"A key role of PFMA is to provide educational resources on how to ensure the full range of pets get the right nutrition and we really value the role of vets and vet nurses being at the front line to pass this information on.
"At PFMA we are here to support the veterinary profession and we have a series of factsheets on popular feeding topics such as ‘Do all small mammals eat the same food’ and ‘Nutrition for indoor birds. Our pet companions fill our lives with love and joy and in return, it’s important we provide the care they need. "
For more information, visit www.pfma.org.uk/statistics